| Name | Abbreviation |
| Diabetic Retinopathy | DR |
| High-Sucrose Diets | HSDs |
| Advanced Glycation End Products | AGEs |
| International Diabetes Federation | IDF |
| Vascular Endothelial Growth Factor | VEGF |
| Vascular Endothelial Growth Factor Receptor | VEGFR |
| Proliferative Diabetic Retinopathy | PDR |
| Non-Proliferative Diabetic Retinopathy | NPDR |
| Diabetic Macular Oedema | DMO |
| Neovascularization of Optic Disc | NVD |
| Neovascularization of Elsewhere | NVE |
| Glycated Hemoglobin A1c | HbA1c |
| Low-Density Lipoprotein Cholesterol | LDL-C |
| Very-Low-Density Lipoprotein Cholesterol | VLDL-C |
| High-Density Lipoprotein Cholesterol | HDL-C |
| Protein Kinase C | PKC |
| Diacylglycerol | DAG |
| Aldose Reductase | AR |
| Tumor Necrosis Factor-α | TNF-α |
| Macrophage Inflammatory Protein-1α | MIP-1α |
| Interleukin-6 | IL-6 |
| Interleukin-8 | IL-8 |
| Receptor for Advanced Glycation End Products | RAGE |
| Reactive Oxygen Species | ROS |
| Blood–Retinal Barrier | BRB |
| World Health Organization | WHO |
| Retinal Ganglion Cells | RGCs |
| Polyunsaturated Fatty Acids | PUFAs |
| Long-chain ω-3 Polyunsaturated Fatty Acids | LCω3PUFAs |
| Deoxyribonucleic Acid | DNA |
| Cyanidin-3-O-Glucoside | C3G |
| Mediterranean Diet | MedDiet |
| Monounsaturated Fatty Acids | MUFAs |
| Dietary Approaches to Stop Hypertension | DASH |